XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.2
10. Segment Information Segment Reporting (Tables)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Segment Reporting [Abstract]    
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Information regarding operating segments for the three months ended September 30, 2021 and 2020 is as follows (in millions):
Life
Science
Clinical
Diagnostics
Other
Operations
Segment net sales 2021$373.5 $372.2 $1.3 
 2020$324.0 $322.2 $1.1 
Segment net profit (loss)2021$105.8 $50.7 $(0.2)
 2020$75.7 $28.8 $(0.6)
Information regarding operating segments for the nine months ended September 30, 2021 and 2020 is as follows (in millions):
Life
Science
Clinical
Diagnostics
Other
Operations
Segment net sales 2021$1,074.2 $1,111.0 $4.6 
 2020$803.2 $945.6 $7.0 
Segment net profit (loss)2021$272.7 $108.9 $(0.4)
 2020$134.9 $83.1 $0.6 
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]   The following reconciles total segment profit to consolidated income before income taxes (in millions):
Three Months EndedNine Months Ended
September 30,September 30,
 2021202020212020
Total segment profit $156.3 $103.9 $381.2 $218.6 
Foreign currency exchange losses, net(2.2)(0.8)(0.5)(2.5)
Change in fair market value of equity securities4,868.7 1,580.4 7,078.8 3,591.5 
Other (expense) income, net(0.6)1.0 16.7 21.5 
Consolidated income before income taxes$5,022.2 $1,684.5 $7,476.2 $3,829.1